Benzimidazole Bearing Thiosemicarbazone Derivatives Act as Potent α-Amylase and α-Glucosidase Inhibitors; Synthesis, Bioactivity Screening and Molecular Docking Study
Authors:
- Hayat UllahHUHayat Ullah
- Shoaib KhanSKShoaib Khan
- Fazal RahimFRFazal Rahim
- Muhammad TahaMTMuhammad Taha
- Rashid IqbalRIRashid Iqbal
- Maliha SarfrazMSMaliha Sarfraz
- Syed Adnan Ali ShahSSSyed Adnan Ali Shah
- Muhammad SajidMSMuhammad Sajid
- Mohamed F. AwadMohamed F. Awad
- Awatif OmranAOAwatif Omran
- Marzough Aziz AlbalawiMAMarzough Aziz Albalawi
- Mahmoud A. AbdelazizMAMahmoud A. Abdelaziz
Open Access
Abstract
Diabetes mellitus is one of the most chronic metabolic diseases. In the past few years, our research group has synthesized and evaluated libraries of heterocyclic analogs against α-glucosidase and α-amylase enzymes and found encouraging results. The current study comprises the evaluation of benzimidazole-bearing thiosemicarbazone as antidiabetic agents. A library of fifteen derivatives (7–21) was synthesized, characterized via different spectroscopic techniques such as HREI-MS, NMR, and screened against α-glucosidase and α-amylase enzymes. All derivatives exhibited excellent to good biological inhibitory potentials. Derivatives 19 (IC50 = 1.30 ± 0.20 µM and 1.20 ± 0.20 µM) and 20 (IC50 = 1.60 ± 0.20 µM and 1.10 ± 0.01 µM) were found to be the most potent among the series when compared with standard drug acarbose (IC50 = 11.29 ± 0.07 and 11.12 ± 0.15 µM, respectively). These derivatives may potentially serve as the lead candidates for the development of new therapeutic representatives. The structure–activity relationship was carried out for all molecules which are mainly based upon the pattern of substituent/s on phenyl rings. Moreover, in silico docking studies were carried out to investigate the active binding mode of selected derivatives with the target enzymes.Keywords
Funding Information
- Taif University Researchers (TURSP-2020/111)
This publication has 33 references indexed in Scilit:
- Adaptive molecular docking method based on information entropy genetic algorithmApplied Soft Computing, 2015
- Design and synthesis of novel benzimidazole derivatives as phosphodiesterase 10A inhibitors with reduced CYP1A2 inhibitionBioorganic & Medicinal Chemistry, 2013
- Novel Benzothiazole, Benzimidazole and Benzoxazole Derivatives as Potential Antitumor Agents: Synthesis and Preliminary in Vitro Biological EvaluationMolecules, 2012
- Design and synthesis of novel benzimidazole derivatives as inhibitors of hepatitis B virusBioorganic & Medicinal Chemistry, 2010
- Phase III Randomized Study of Bendamustine Compared With Chlorambucil in Previously Untreated Patients With Chronic Lymphocytic LeukemiaJournal of Clinical Oncology, 2009
- Synthesis and antiprotozoal activity of novel 1-methylbenzimidazole derivativesBioorganic & Medicinal Chemistry, 2009
- In vitro studies of eggplant (Solanum melongena) phenolics as inhibitors of key enzymes relevant for type 2 diabetes and hypertensionBioresource Technology, 2008
- Nanomolar concentrations of nocodazole alter microtubule dynamic instability in vivo and in vitro.Molecular Biology of the Cell, 1997
- Character of a wheat amylase inhibitor preparation and effects on fasting human pancreaticobiliary secretions and hormonesGastroenterology, 1996
- Effect of a Purified Amylase Inhibitor on Carbohydrate Metabolism After a Mixed Meal in Healthy HumansMayo Clinic Proceedings, 1987